Skip to main content

What drives pharma m&a – McKinsey

By October 15, 2018News
dna-blood-pixa

dna-blood-pixa

There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios.

{iframe}https://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights/whats-behind-the-pharmaceutical-sectors-m-and-a-push?cid=other-eml-alt-mip-mck-oth-1810&hlkid=ecb68189d4104c6e9fab9262b429b597&hctky=3027237&hdpid=41bb6d4e-76bc-4a0d-bac4-5c67e2d62194{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.